Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD

References

• Global strategy for prevention, diagnosis, and management of COPD2018 Available from: www.goldcopd.orgAccessed November 5, 2018
   Google Scholar
• FDA approved drugs for pulmonary/respiratory diseases Available from: https://www.centerwatch.com/drug-information/fda-approved-drugs/therapeutic-area/18/pulmonary-respiratory-diseasesAccessed November 5, 2018
   Google Scholar
• PitcairnGReaderSPaviaDNewmanSDeposition of corticosteroid aerosol in the human lung by Respimat soft mist inhaler compared to deposition by metered dose inhaler or by Turbuhaler dry powder inhalerJ Aerosol Med200518326427216181001
   PubMedGoogle Scholar
• ClarkARHollingworthAMThe relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers – implications for in vitro testingJ Aerosol Med1993629911010146277
   PubMedGoogle Scholar
• GhoshSOharJADrummondMBPeak inspiratory flow rate in chronic obstructive pulmonary disease: implications for dry powder inhalersJ Aerosol Med Pulm Drug Deliv201730638138728933581
   PubMed Web of Science ®Google Scholar
• HaidlPHeindlSSiemonKBernackaMCloesRMInhalation device requirements for patients’ inhalation maneuversRespir Med2016118657527578473
   PubMed Web of Science ®Google Scholar
• FinlayWHMartinARModeling of aerosol deposition with interface devicesJ Aerosol Med200720Suppl 1S19S28 discussion S27–S1817411402
   PubMedGoogle Scholar
• ClarkARThe role of inspiratory pressures in determining the flow rates though dry powder inhalers; a reviewCurr Pharm Des201521273974398326290203
   PubMed Web of Science ®Google Scholar
• JanssensWVandenbrandePHardemanEInspiratory flow rates at different levels of resistance in elderly COPD patientsEur Respir J2008311788317898020
   PubMed Web of Science ®Google Scholar
• MahlerDAPeak inspiratory flow rate as a criterion for dry powder inhaler use in chronic obstructive pulmonary diseaseAnn Am Thorac Soc20171471103110728481631
   PubMed Web of Science ®Google Scholar
• YokoyamaHYamamuraYOzekiTIgaTYamadaYAnalysis of relationship between peak inspiratory flow rate and amount of drug delivered to lungs following inhalation of fluticasone propionate with a DiskhalerBiol Pharm Bull200730116216417202678
   PubMed Web of Science ®Google Scholar
• ChrystynHIs inhalation rate important for a dry powder inhaler? Using the In-Check dial to identify these ratesRespir Med200397218118712587970
   PubMed Web of Science ®Google Scholar
• DewarMHJamiesonAMcleanACromptonGKPeak inspiratory flow through Turbuhaler in chronic obstructive airways diseaseRespir Med199993534234410464901
   PubMed Web of Science ®Google Scholar
• MahlerDAWatermanLAGiffordAHPrevalence and COPD phenotype for a suboptimal peak inspiratory flow rate against the simulated resistance of the Diskus® dry powder inhalerJ Aerosol Med Pulm Drug Deliv201326317417923025451
   PubMed Web of Science ®Google Scholar
• MalmbergLPRytiläPHapponenPHaahtelaTInspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: age and gender rather than severity mattersInt J Chron Obstruct Pulmon Dis2010525726220714380
   PubMedGoogle Scholar
• van der PalenJPeak inspiratory flow through diskus and turbuhaler, measured by means of a peak inspiratory flow meter (In-Check dial)Respir Med200397328528912645837
   PubMed Web of Science ®Google Scholar
• LohCHPetersSPLovingsTMOharJASuboptimal inspiratory flow rates are associated with chronic obstructive pulmonary disease and all-cause readmissionsAnn Am Thorac Soc20171481305131128406710
   PubMed Web of Science ®Google Scholar
• SandersMJGuiding inspiratory flow: development of the In-Check dial G16, a tool for improving inhaler techniquePulm Med2017201717
   Web of Science ®Google Scholar
• JonesPWHardingGBerryPWiklundIChenWHKline LeidyNDevelopment and first validation of the COPD assessment testEur Respir J200934364865419720809
   PubMed Web of Science ®Google Scholar
• TungLLDuarteAMillsJMartinezJSharmaGPrevalence of low peak inspiratory flow rate in ambulatory patients with COPDAm J Respir Critic Care Med2017195A5674
   Web of Science ®Google Scholar
• SharmaGMahlerDAMayorgaVMDeeringKLHarshawOGanapathyVPrevalence of low peak inspiratory flow rate at discharge in patients hospitalized for COPD exacerbationChronic Obstr Pulm Dis20174321722428848933
   PubMed Web of Science ®Google Scholar
• SeheultJNCostelloSTeeKCInvestigating the relationship between peak inspiratory flow rate and volume of inhalation from a Diskus™ inhaler and baseline Spirometric parameters: a cross-sectional studySpringerplus2014349625279290
   PubMedGoogle Scholar
• SharmaGGMahlerDAMayorgaVDeeringKGanapathyVPrevalence of Low Peak Inspiratory Flow Rate (PIFR) in Chronic Obstructive Pulmonary Disease (COPD) Patients at Discharge After an Exacerbation – Interim Findings from a Prospective StudyAmer J Resp Crit Care Med2016193A1506
   Web of Science ®Google Scholar
• KawamatawongTKhiawwanSPornsuriyasakPPeak inspiratory flow rate measurement by using In-Check dial for the different inhaler devices in elderly with obstructive airway diseasesJ Asthma Allergy201710172128260934
   PubMed Web of Science ®Google Scholar
• PrimeDde BackerWHamiltonMEffect of disease severity in asthma and chronic obstructive pulmonary disease on Inhaler-Specific inhalation profiles through the ELLIPTA® dry powder inhalerJ Aerosol Med Pulm Drug Deliv201528648649726372467
   PubMed Web of Science ®Google Scholar
• SeheultJNO’ConnellPTeeKCThe acoustic features of inhalation can be used to quantify aerosol delivery from a Diskus™ dry powder inhalerPharm Res201431102735274724867420
   PubMed Web of Science ®Google Scholar
• BroedersMEMolemaJHopWCFolgeringHTInhalation profiles in asthmatics and COPD patients: reproducibility and effect of instructionJ Aerosol Med200316213114112823907
   PubMedGoogle Scholar